Willemssen, F.; de Lussanet de la Sablonière, Q.; Bos, D.; IJzermans, J.; De Man, R.; Dwarkasing, R.
Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC. Cancers 2022, 14, 3961.
https://doi.org/10.3390/cancers14163961
AMA Style
Willemssen F, de Lussanet de la Sablonière Q, Bos D, IJzermans J, De Man R, Dwarkasing R.
Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC. Cancers. 2022; 14(16):3961.
https://doi.org/10.3390/cancers14163961
Chicago/Turabian Style
Willemssen, François, Quido de Lussanet de la Sablonière, Daniel Bos, Jan IJzermans, Robert De Man, and Roy Dwarkasing.
2022. "Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC" Cancers 14, no. 16: 3961.
https://doi.org/10.3390/cancers14163961
APA Style
Willemssen, F., de Lussanet de la Sablonière, Q., Bos, D., IJzermans, J., De Man, R., & Dwarkasing, R.
(2022). Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC. Cancers, 14(16), 3961.
https://doi.org/10.3390/cancers14163961
